+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

R

Actively Recruiting

This trial evaluates the combination of Navlimetostat BMS-986504, pembrolizumab, and chemotherapy compared to placebo with pembrolizumab and chemotherapy in adults with first-line metastatic non-small cell lung cancer having homozygous MTAP deletion. The study is a randomized, double-blind Phase 23 trial sponsored by Bristol-Myers Squibb, aiming to understand treatment benefits in this specific patient group. Participants must have measurable metastatic NSCLC, no prior systemic therapy for metastatic disease, and meet performance status criteria. Participants receive either Navlimetostat plus pembrolizumab and chemotherapy or placebo plus pembrolizumab and chemotherapy. Chemotherapy may include drugs such as cisplatin, carboplatin, pemetrexed, paclitaxel, or nab-paclitaxel, given on specified days at specified doses. Treatment is administered in the first-line metastatic setting, with detailed dosing and combinations determined by study protocols. Randomization assigns participants to one of multiple arms to compare the investigational combination against placebo. Throughout the study, participants are monitored for progression-free survival up to 2 years and 5 years, overall survival up to 5 years, as well as response rates and safety outcomes including adverse events and laboratory abnormalities. Assessments follow RECIST v1.1 criteria with independent and investigator reviews. Safety monitoring includes tracking serious adverse events and treatment-related side effects up to 90 days after treatment ends. The study duration extends to the primary completion date in August 2031, with ongoing evaluations for up to 5 years post-treatment.

Age: 18Years +All GendersPhase 2Phase 3
321 locations
I

Actively Recruiting

Researchers are evaluating a complex intervention to improve advance care planning ACP for severely ill elderly people living at home who are acutely admitted to hospital. This cluster randomized study involves twelve Norwegian geriatric hospital units and aims to enhance patient and family involvement in treatment decisions, improve quality of life, and support ethical and legal care planning. The project also explores barriers and facilitators to implementing ACP at clinical, health service, and governmental levels, including economic analyses. The intervention group receives a comprehensive support program that includes leadership commitment, training for staff, implementation teams, ACP coordinators, and practical tools such as guidelines and documentation templates. The control group receives no implementation support during the trial but will be offered the program afterward. The study period includes baseline, 9-month, and 18-month assessments for the intervention group and baseline and 18-month assessments for the control group. Participants will undergo questionnaires and interviews with patients, relatives, clinicians, and staff at multiple time points before, during, and after the implementation. Data from patient records and national health registers will be collected to assess the fidelity of ACP implementation, clinical outcomes, communication quality, and cost-effectiveness. The trial runs until December 2026 and includes various measures to evaluate the impact of the support program on ACP delivery and related outcomes.

Age: 70Years +All GendersPhase Not Applicable
12 locations
R

Actively Recruiting

Ankle fractures are common injuries occurring in about 1 in 800 people each year. This research evaluates whether repairing the deltoid ligament in unstable ankle fractures improves joint stability, functional outcomes, and may help prevent long-term osteoarthritis. The study focuses on patients with severe ankle fractures, as these injuries can significantly reduce daily function and affect the ability to work, potentially increasing community healthcare costs. Participants will be randomly assigned to one of two groups one receiving standard treatment involving plate and screw fixation of the lateral malleolus only, and the other receiving the same standard treatment plus an additional surgical repair suture of the deep deltoid ligament. The ligament repair involves a specific surgical technique where the ligament is reattached to an anchor in the talus. This multicenter randomized controlled study aims to compare these approaches in unstable Weber B ankle fractures. During the study, participants will be evaluated through patient-reported functional outcomes and radiological stability measurements at 1 and 2 years after injury, with functional outcome data also collected at 5 years. Additional assessments include general health, pain levels, ankle arthritis development, and foot and ankle function scores collected at various intervals up to 5 years. Researchers will monitor the long-term effects of ligament repair on ankle stability and function, with follow-up visits planned to assess recovery and outcomes.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
9 locations